The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Eyedrops-Global Market Insights and Sales Trends 2025

Eyedrops-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1812997

No of Pages : 126

Ask Your Query
Synopsis
Eye drops or eyedrops are liquid drops applied directly to the surface of the eye usually in small amounts such as a single drop or a few drops.
The global Eyedrops market size is expected to reach US$ 9956.2 million by 2029, growing at a CAGR of 1.4% from 2023 to 2029. The market is mainly driven by the significant applications of Eyedrops in various end use industries. The expanding demands from the Eye Disease, Eye Care and Others,, are propelling Eyedrops market. Antibiotics Eyedrops, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hormonal Eyedrops segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Eyedrops, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Eyedrops market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Eyedrops market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Eyedrops sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Eyedrops covered in this report include Bausch + Lomb, Abbott, Alcon, Allergan, Rohto Pharmaceutical, Clear Eyes, Johnson & Johnson, Sager Pharma and Similasan, etc.
The global Eyedrops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bausch + Lomb
Abbott
Alcon
Allergan
Rohto Pharmaceutical
Clear Eyes
Johnson & Johnson
Sager Pharma
Similasan
TheraTears
Santen Pharmaceutical
Bayer
Novartis
Harrow Health
Thea pharmaceuticals
URSAPHARM
OmniVision Pharma
Akorn
The United Laboratories
Prestige Consumer Healthcare
Renhe
RUIZHU
Qianliming
Novax Pharma
Global Eyedrops market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Eyedrops market, Segment by Type:
Antibiotics Eyedrops
Hormonal Eyedrops
Health Care Eyedrops
Global Eyedrops market, by Application
Eye Disease
Eye Care
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Eyedrops manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Eyedrops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Eyedrops Market Overview
1.1 Eyedrops Product Overview
1.2 Eyedrops Market Segment by Type
1.2.1 Antibiotics Eyedrops
1.2.2 Hormonal Eyedrops
1.2.3 Health Care Eyedrops
1.3 Global Eyedrops Market Size by Type
1.3.1 Global Eyedrops Market Size Overview by Type (2018-2029)
1.3.2 Global Eyedrops Historic Market Size Review by Type (2018-2023)
1.3.3 Global Eyedrops Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Eyedrops Sales Breakdown by Type (2018-2023)
1.4.2 Europe Eyedrops Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Eyedrops Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Eyedrops Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Eyedrops Sales Breakdown by Type (2018-2023)
2 Global Eyedrops Market Competition by Company
2.1 Global Top Players by Eyedrops Sales (2018-2023)
2.2 Global Top Players by Eyedrops Revenue (2018-2023)
2.3 Global Top Players by Eyedrops Price (2018-2023)
2.4 Global Top Manufacturers Eyedrops Manufacturing Base Distribution, Sales Area, Product Type
2.5 Eyedrops Market Competitive Situation and Trends
2.5.1 Eyedrops Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Eyedrops Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eyedrops as of 2022)
2.7 Date of Key Manufacturers Enter into Eyedrops Market
2.8 Key Manufacturers Eyedrops Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Eyedrops Status and Outlook by Region
3.1 Global Eyedrops Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Eyedrops Historic Market Size by Region
3.2.1 Global Eyedrops Sales in Volume by Region (2018-2023)
3.2.2 Global Eyedrops Sales in Value by Region (2018-2023)
3.2.3 Global Eyedrops Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Eyedrops Forecasted Market Size by Region
3.3.1 Global Eyedrops Sales in Volume by Region (2024-2029)
3.3.2 Global Eyedrops Sales in Value by Region (2024-2029)
3.3.3 Global Eyedrops Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Eyedrops by Application
4.1 Eyedrops Market Segment by Application
4.1.1 Eye Disease
4.1.2 Eye Care
4.1.3 Others
4.2 Global Eyedrops Market Size by Application
4.2.1 Global Eyedrops Market Size Overview by Application (2018-2029)
4.2.2 Global Eyedrops Historic Market Size Review by Application (2018-2023)
4.2.3 Global Eyedrops Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Eyedrops Sales Breakdown by Application (2018-2023)
4.3.2 Europe Eyedrops Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Eyedrops Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Eyedrops Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Eyedrops Sales Breakdown by Application (2018-2023)
5 North America Eyedrops by Country
5.1 North America Eyedrops Historic Market Size by Country
5.1.1 North America Eyedrops Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Eyedrops Sales in Volume by Country (2018-2023)
5.1.3 North America Eyedrops Sales in Value by Country (2018-2023)
5.2 North America Eyedrops Forecasted Market Size by Country
5.2.1 North America Eyedrops Sales in Volume by Country (2024-2029)
5.2.2 North America Eyedrops Sales in Value by Country (2024-2029)
6 Europe Eyedrops by Country
6.1 Europe Eyedrops Historic Market Size by Country
6.1.1 Europe Eyedrops Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Eyedrops Sales in Volume by Country (2018-2023)
6.1.3 Europe Eyedrops Sales in Value by Country (2018-2023)
6.2 Europe Eyedrops Forecasted Market Size by Country
6.2.1 Europe Eyedrops Sales in Volume by Country (2024-2029)
6.2.2 Europe Eyedrops Sales in Value by Country (2024-2029)
7 Asia-Pacific Eyedrops by Region
7.1 Asia-Pacific Eyedrops Historic Market Size by Region
7.1.1 Asia-Pacific Eyedrops Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Eyedrops Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Eyedrops Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Eyedrops Forecasted Market Size by Region
7.2.1 Asia-Pacific Eyedrops Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Eyedrops Sales in Value by Region (2024-2029)
8 Latin America Eyedrops by Country
8.1 Latin America Eyedrops Historic Market Size by Country
8.1.1 Latin America Eyedrops Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Eyedrops Sales in Volume by Country (2018-2023)
8.1.3 Latin America Eyedrops Sales in Value by Country (2018-2023)
8.2 Latin America Eyedrops Forecasted Market Size by Country
8.2.1 Latin America Eyedrops Sales in Volume by Country (2024-2029)
8.2.2 Latin America Eyedrops Sales in Value by Country (2024-2029)
9 Middle East and Africa Eyedrops by Country
9.1 Middle East and Africa Eyedrops Historic Market Size by Country
9.1.1 Middle East and Africa Eyedrops Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Eyedrops Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Eyedrops Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Eyedrops Forecasted Market Size by Country
9.2.1 Middle East and Africa Eyedrops Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Eyedrops Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bausch + Lomb
10.1.1 Bausch + Lomb Company Information
10.1.2 Bausch + Lomb Introduction and Business Overview
10.1.3 Bausch + Lomb Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bausch + Lomb Eyedrops Products Offered
10.1.5 Bausch + Lomb Recent Development
10.2 Abbott
10.2.1 Abbott Company Information
10.2.2 Abbott Introduction and Business Overview
10.2.3 Abbott Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Eyedrops Products Offered
10.2.5 Abbott Recent Development
10.3 Alcon
10.3.1 Alcon Company Information
10.3.2 Alcon Introduction and Business Overview
10.3.3 Alcon Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Alcon Eyedrops Products Offered
10.3.5 Alcon Recent Development
10.4 Allergan
10.4.1 Allergan Company Information
10.4.2 Allergan Introduction and Business Overview
10.4.3 Allergan Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Allergan Eyedrops Products Offered
10.4.5 Allergan Recent Development
10.5 Rohto Pharmaceutical
10.5.1 Rohto Pharmaceutical Company Information
10.5.2 Rohto Pharmaceutical Introduction and Business Overview
10.5.3 Rohto Pharmaceutical Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Rohto Pharmaceutical Eyedrops Products Offered
10.5.5 Rohto Pharmaceutical Recent Development
10.6 Clear Eyes
10.6.1 Clear Eyes Company Information
10.6.2 Clear Eyes Introduction and Business Overview
10.6.3 Clear Eyes Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Clear Eyes Eyedrops Products Offered
10.6.5 Clear Eyes Recent Development
10.7 Johnson & Johnson
10.7.1 Johnson & Johnson Company Information
10.7.2 Johnson & Johnson Introduction and Business Overview
10.7.3 Johnson & Johnson Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Johnson & Johnson Eyedrops Products Offered
10.7.5 Johnson & Johnson Recent Development
10.8 Sager Pharma
10.8.1 Sager Pharma Company Information
10.8.2 Sager Pharma Introduction and Business Overview
10.8.3 Sager Pharma Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sager Pharma Eyedrops Products Offered
10.8.5 Sager Pharma Recent Development
10.9 Similasan
10.9.1 Similasan Company Information
10.9.2 Similasan Introduction and Business Overview
10.9.3 Similasan Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Similasan Eyedrops Products Offered
10.9.5 Similasan Recent Development
10.10 TheraTears
10.10.1 TheraTears Company Information
10.10.2 TheraTears Introduction and Business Overview
10.10.3 TheraTears Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.10.4 TheraTears Eyedrops Products Offered
10.10.5 TheraTears Recent Development
10.11 Santen Pharmaceutical
10.11.1 Santen Pharmaceutical Company Information
10.11.2 Santen Pharmaceutical Introduction and Business Overview
10.11.3 Santen Pharmaceutical Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Santen Pharmaceutical Eyedrops Products Offered
10.11.5 Santen Pharmaceutical Recent Development
10.12 Bayer
10.12.1 Bayer Company Information
10.12.2 Bayer Introduction and Business Overview
10.12.3 Bayer Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bayer Eyedrops Products Offered
10.12.5 Bayer Recent Development
10.13 Novartis
10.13.1 Novartis Company Information
10.13.2 Novartis Introduction and Business Overview
10.13.3 Novartis Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Novartis Eyedrops Products Offered
10.13.5 Novartis Recent Development
10.14 Harrow Health
10.14.1 Harrow Health Company Information
10.14.2 Harrow Health Introduction and Business Overview
10.14.3 Harrow Health Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Harrow Health Eyedrops Products Offered
10.14.5 Harrow Health Recent Development
10.15 Thea pharmaceuticals
10.15.1 Thea pharmaceuticals Company Information
10.15.2 Thea pharmaceuticals Introduction and Business Overview
10.15.3 Thea pharmaceuticals Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Thea pharmaceuticals Eyedrops Products Offered
10.15.5 Thea pharmaceuticals Recent Development
10.16 URSAPHARM
10.16.1 URSAPHARM Company Information
10.16.2 URSAPHARM Introduction and Business Overview
10.16.3 URSAPHARM Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.16.4 URSAPHARM Eyedrops Products Offered
10.16.5 URSAPHARM Recent Development
10.17 OmniVision Pharma
10.17.1 OmniVision Pharma Company Information
10.17.2 OmniVision Pharma Introduction and Business Overview
10.17.3 OmniVision Pharma Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.17.4 OmniVision Pharma Eyedrops Products Offered
10.17.5 OmniVision Pharma Recent Development
10.18 Akorn
10.18.1 Akorn Company Information
10.18.2 Akorn Introduction and Business Overview
10.18.3 Akorn Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Akorn Eyedrops Products Offered
10.18.5 Akorn Recent Development
10.19 The United Laboratories
10.19.1 The United Laboratories Company Information
10.19.2 The United Laboratories Introduction and Business Overview
10.19.3 The United Laboratories Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.19.4 The United Laboratories Eyedrops Products Offered
10.19.5 The United Laboratories Recent Development
10.20 Prestige Consumer Healthcare
10.20.1 Prestige Consumer Healthcare Company Information
10.20.2 Prestige Consumer Healthcare Introduction and Business Overview
10.20.3 Prestige Consumer Healthcare Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Prestige Consumer Healthcare Eyedrops Products Offered
10.20.5 Prestige Consumer Healthcare Recent Development
10.21 Renhe
10.21.1 Renhe Company Information
10.21.2 Renhe Introduction and Business Overview
10.21.3 Renhe Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Renhe Eyedrops Products Offered
10.21.5 Renhe Recent Development
10.22 RUIZHU
10.22.1 RUIZHU Company Information
10.22.2 RUIZHU Introduction and Business Overview
10.22.3 RUIZHU Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.22.4 RUIZHU Eyedrops Products Offered
10.22.5 RUIZHU Recent Development
10.23 Qianliming
10.23.1 Qianliming Company Information
10.23.2 Qianliming Introduction and Business Overview
10.23.3 Qianliming Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.23.4 Qianliming Eyedrops Products Offered
10.23.5 Qianliming Recent Development
10.24 Novax Pharma
10.24.1 Novax Pharma Company Information
10.24.2 Novax Pharma Introduction and Business Overview
10.24.3 Novax Pharma Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.24.4 Novax Pharma Eyedrops Products Offered
10.24.5 Novax Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Eyedrops Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Eyedrops Industrial Chain Analysis
11.4 Eyedrops Market Dynamics
11.4.1 Eyedrops Industry Trends
11.4.2 Eyedrops Market Drivers
11.4.3 Eyedrops Market Challenges
11.4.4 Eyedrops Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Eyedrops Distributors
12.3 Eyedrops Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock